News

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
Dr Tami Nussbaum, Takeda, shares her journey from neurology to pharma, challenges in rare disease and how she avoids burnout.
Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...
INTENSIVE blood pressure (BP) control in patients with hypertension reduces the risk of all-cause dementia by 15%, according ...
Volatile anaesthetics and propofol show no significant difference in intraoperative urine output, study suggests.
New clinical insights support U.S. doctors in using transoral robotic surgery (TORS) to personalize treatment plans for ...
A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis ...
Researchers retrospectively analysed data from 368 patients with MSI-H colon cancer across two academic centres. Patients ...
New review reveals Lewy Body Dementia research in Latin America is significantly underrepresented, with major gaps in ...
A RECENT large-scale study has examined the association between metformin use and the development of diabetic peripheral ...
Discover a recent study that investigated the effects of acupuncture and herbal remedies on urticaria. Learn more.
Cutaneous warts are benign epithelial lesions caused by human papillomavirus (HPV) and are common entities, affecting nearly ...